DoD Releases Pyridostigmine Bromide RAND Report

Immediately following the regularly scheduled Tuesday, 1:30 p.m. EDT Department of Defense news briefing in Pentagon Room 2E781, Under Secretary of the Army Bernard Rostker, Assistant Secretary of Defense for Health Affairs Dr. Sue Bailey, and RAND researcher Dr. Beatrice Golomb will discuss the findings of a scientific literature review released today which examines the safety and effectiveness of (PB). Pyridostigmine bromide was used during the Gulf War as a pretreatment to protect military personnel from the nerve agent Soman. The work was performed to identify hypotheses or theories that might link PB to illnesses among some Gulf War veterans.